Login
$BIAF
$1.98 -$0.02 (1.0%) After hours

Company Executives

Officer Age In this role Joined 2025 pay Source
Maria Zannes Also a director
President, CEO, and Director
70 Since 2014
12 years
Not stated Not reported
James Michael Edwards
Chief Financial Officer
59 Since 2024
2 years
Not stated $368,455
Xavier Reveles
Chief Operating Officer
57 Since 2023
3 years
2017 Not reported
Steven Girgenti Also a director
Executive Chairman of the Board
79 Since 2014
12 years
Not stated Not reported
Timothy P. Zannes
Executive Vice President, Secretary, and General Counsel
73 Since 2014
12 years
Not stated Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
8
serving now
Independent
5 of 5
stated in the proxy; 3 not stated
Average tenure
6.2 years
from year joined
CEO also chairs the board
No
Steven Girgenti
Director Age On board Independent 2025 pay Source
Steven Girgenti
79 2014
12 years
Not stated Not stated
Maria Zannes
70 2014
12 years
Not stated Paid as CEO
Peter Knight
75 2018
8 years
Independent $61,178
Jamie Platt
59 2023
3 years
Independent $61,178
Roberto Rios
68 2025
1 year
Independent $11,250
John J. Oppenheimer
65 2025
1 year
Independent $9,375
Robert Anderson Leaving at the meeting
Not stated Not stated Independent $58,678
Roby Joyce Leaving at the meeting
Not stated Not stated Not stated $392,011

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

8 disclosed in the proxy filed Mar 16, 2026
Dr. Roby Joyce
Medical Director and Laboratory Director of the clinical pathology laboratory prior to the acquisition
$3,500,000
September 18, 2023

PPLS acquired the laboratory assets of Village Oaks for $3,500,000, of which $1,000,000 was paid by issuing 564,972 restricted shares to the Joyce Trust

With Village Oaks Pathology Services, P.A. Open in proxy
Dr. Roby Joyce
holder of 100% of the issued and outstanding stock of Village Oaks
Amount not stated

Management Services Agreement under which PPLS provides management and administrative services to Village Oaks for a management fee of 70% of net revenues

With Village Oaks Pathology Services, P.A. Open in proxy
Dr. Roby Joyce
holder of 100% of the issued and outstanding stock of Village Oaks
Amount not stated

Professional Services Agreement under which Village Oaks provides pathology interpretation services to PPLS

With Village Oaks Pathology Services, P.A. Open in proxy
Dr. Roby Joyce
holder of 100% of the issued and outstanding stock of Village Oaks
Amount not stated

Succession Agreement restricting disposal of Village Oaks equity and providing for transfer of Dr. Joyce's equity interest upon specified events

With PPLS Open in proxy
Dr. Roby Joyce
appointed to serve on our Board; Medical Director and Laboratory Director of PPLS
Base salary of $333,333.34 per year
three-year term

Executive Employment Agreement for a three-year term as Medical Director and Laboratory Director of PPLS

With the Company Open in proxy
Mr. Girgenti
holder of outstanding warrants
Amount not stated
September 17, 2023

Amendment of the terms of outstanding warrants held by Mr. Girgenti, the Cranye Girgenti Testamentary Trust, Gary Rubin, The Harvey Sandler Revocable Trust, Ms. Zannes and Dr. Joyce, so they were not exercisable until the authorized share increase

Timothy P. Zannes
brother of Maria Zannes, our Chief Executive Officer
Amount not stated
fiscal years 2024 and 2025

Employment as General Counsel and Secretary with salary and bonus

Peter Zannes Fatland
son of Maria Zannes, our Chief Executive Officer
Annual base salary of $80,000
2026

Employment offer letter as Associate Pulmonary Sales Executive with base salary, variable compensation and expense reimbursement

With the Company Open in proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support